Skip to main content

Rocklage Scott M's Form 4 filing

scPharmaceuticals Inc. (SCPH) · filed Sep 8, 2022

Accession no.
0001209191-22-049235
Filed
Sep 8, 2022, 7:58 PM ET
Trade date
Sep 6-7, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions. Open-market sales total $1.10M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rocklage Scott MCIK 000121901410% Owner
Diekman John DCIK 000124035710% Owner
5AM Partners IV, LLCCIK 000158931410% Owner
5AM Ventures IV, L.P.CIK 000158931510% Owner
5AM Co-Investors IV, L.P.CIK 000159336110% Owner
Schwab Andrew J.CIK 000159854910% Owner
5AM Opportunities I, L.P.CIK 000175300010% Owner
5AM Opportunities I (GP), LLCCIK 000179077810% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 6, 2022Common StockSSaleDisposed−21,702$5.52−$119,795.042,881,505Indirect
Sep 6, 2022Common StockSSaleDisposed−904$5.52−$4,990.08120,062Indirect
Sep 6, 2022Common StockSSaleDisposed−4,016$5.52−$22,168.32533,285Indirect
Sep 7, 2022Common StockSSaleDisposed−163,034$4.75−$774,411.52,718,471Indirect
Sep 7, 2022Common StockSSaleDisposed−6,793$4.75−$32,266.75113,269Indirect
Sep 7, 2022Common StockSSaleDisposed−30,173$4.75−$143,321.75503,112Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)